Ke Deng

  • Research assistant

 

 

 

Publications 2021

Pällmann N, Deng K, Livgård M, Tesikova M, Jin Y, Frengen NS, Kahraman N, Mokhlis HM, Ozpolat B, Kildal W, Danielsen HE, Fazli L, Rennie PS, Banerjee PP, Üren A, Jin Y, Kuzu OF, Saatcioglu F (2021)
Stress-Mediated Reprogramming of Prostate Cancer One-Carbon Cycle Drives Disease Progression
Cancer Res, 81 (15), 4066-4078
DOI 10.1158/0008-5472.CAN-20-3956, PubMed 34183356

Publications 2020

Yin YP, Shi WH, Deng K, Liu XL, Li H, Lv XT, Lui VWY, Ding C, Hong B, Lin WC (2020)
Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer
Acta Pharmacol Sin, 42 (8), 1298-1310
DOI 10.1038/s41401-020-00544-w, PubMed 33139838

Publications 2019

Li H, Wang H, Deng K, Han W, Hong B, Lin W (2019)
The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer
Cancer Biomark, 24 (1), 51-59
DOI 10.3233/CBM-181692, PubMed 30614795

Publications 2018

Deng K, Shen J, Wang W, Li M, Li H, Chen C, Zhao H, Zhang M, Xue T, Liu Q, Lui VWY, Hong B, Lin W (2018)
Sodium chloride (NaCl) potentiates digoxin-induced anti-tumor activity in small cell lung cancer
Cancer Biol Ther, 20 (1), 52-64
DOI 10.1080/15384047.2018.1504723, PubMed 30183476

Publications 2017

Hong B, Wang H, Deng K, Wang W, Dai H, Yan Lui VW, Lin W (2017)
Combination treatment of RAD001 and BEZ235 exhibits synergistic antitumor activity via down-regulation of p-4E-BP1/Mcl-1 in small cell lung cancer
Oncotarget, 8 (63), 106486-106498
DOI 10.18632/oncotarget.18984, PubMed 29290965

Wang H, Hong B, Li X, Deng K, Li H, Yan Lui VW, Lin W (2017)
JQ1 synergizes with the Bcl-2 inhibitor ABT-263 against MYCN-amplified small cell lung cancer
Oncotarget, 8 (49), 86312-86324
DOI 10.18632/oncotarget.21146, PubMed 29156797

Page visits: 61